Parnassus Investments LLC raised its position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 26.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 580,939 shares of the medical research company’s stock after acquiring an additional 120,483 shares during the period. Parnassus Investments LLC owned approximately 0.21% of Agilent Technologies worth $79,048,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Core Wealth Advisors LLC purchased a new stake in Agilent Technologies during the fourth quarter valued at about $26,000. Board of the Pension Protection Fund purchased a new stake in Agilent Technologies during the fourth quarter valued at about $27,000. Navalign LLC purchased a new stake in Agilent Technologies during the fourth quarter valued at about $27,000. Entrust Financial LLC purchased a new stake in Agilent Technologies during the fourth quarter valued at about $31,000. Finally, Torren Management LLC purchased a new stake in Agilent Technologies during the fourth quarter valued at about $32,000.
Agilent Technologies Price Performance
Shares of NYSE A opened at $129.37 on Friday. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The business has a 50-day moving average of $119.94 and a 200-day moving average of $127.85. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The company has a market capitalization of $36.54 billion, a price-to-earnings ratio of 25.98, a PEG ratio of 2.34 and a beta of 1.26.
Agilent Technologies Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s payout ratio is 20.48%.
Wall Street Analyst Weigh In
A has been the subject of a number of research reports. Robert W. Baird boosted their price target on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Royal Bank Of Canada started coverage on Agilent Technologies in a research report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 target price for the company. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. UBS Group decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Finally, Barclays upped their target price on Agilent Technologies from $140.00 to $145.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $160.93.
Agilent Technologies Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Read More
- Five stocks we like better than Agilent Technologies
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
